MedPath
NMPA Approval

Netupitant and Palonosetron Hydrochloride Capsules

国药准字HJ20190046

April 3, 2024

H20190046

Drug Information

奈妥匹坦帕洛诺司琼胶囊

奥康泽

胶囊剂

每粒硬胶囊含奈妥匹坦0.3g(0.1g/片×3片)和盐酸帕洛诺司琼0.5mg(以C₁₉H₂₄N₂O计,软胶囊1粒)

化学药品

April 3, 2024

April 2, 2029

Company Information

Applicant Company

Via Pian Scairolo 9,6912 Lugano-Pazzallo, Switzerland

Manufacturing Company

Damastown, Mulhuddart, Dublin 15, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奈妥匹坦帕洛诺司琼胶囊 - NMPA 批准文号 | MedPath